{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:18:32Z","timestamp":1788297512795,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004543","name":"Chinese Scholarship Council","doi-asserted-by":"crossref","award":["202108370215"],"award-info":[{"award-number":["202108370215"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swiss Foundation for Research on Muscle Disease (FSRMM) the EMPIRIS foundation"},{"name":"University Hospital of Zurich"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92530-7","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:15:31Z","timestamp":1741158931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The landscape of renal protein S-acylation in mice with lipid-induced nephrotoxicity"],"prefix":"10.1038","volume":"15","author":[{"given":"Fangrui","family":"Xiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold E.","family":"Wolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Museer A.","family":"Lone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"92530_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","volume":"97","author":"AS Levey","year":"2020","unstructured":"Levey, A. S. et al. Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 97, 1117\u20131129. https:\/\/doi.org\/10.1016\/j.kint.2020.02.010 (2020).","journal-title":"Kidney Int."},{"key":"92530_CR2","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas, M. C. et al. Diabetic kidney disease. Nat. Rev. Dis Primers 1, 15018. https:\/\/doi.org\/10.1038\/nrdp.2015.18 (2015).","journal-title":"Nat. Rev. Dis Primers"},{"key":"92530_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha, V. et al. Chronic kidney disease: Global dimension and perspectives. Lancet 382, 260\u2013272. https:\/\/doi.org\/10.1016\/S0140-6736(13)60687-X (2013).","journal-title":"Lancet"},{"key":"92530_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","volume":"63","author":"AI Adler","year":"2003","unstructured":"Adler, A. I. et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 63, 225\u2013232. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00712.x (2003).","journal-title":"Kidney Int."},{"key":"92530_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2337\/diabetes.53.1.179","volume":"53","author":"TY Wong","year":"2004","unstructured":"Wong, T. Y., Shankar, A., Klein, R. & Klein, B. E. Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes 53, 179\u2013184. https:\/\/doi.org\/10.2337\/diabetes.53.1.179 (2004).","journal-title":"Diabetes"},{"key":"92530_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","volume":"160","author":"CT Valmadrid","year":"2000","unstructured":"Valmadrid, C. T., Klein, R., Moss, S. E. & Klein, B. E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Internal Med. 160, 1093\u20131100. https:\/\/doi.org\/10.1001\/archinte.160.8.1093 (2000).","journal-title":"Arch. Internal Med."},{"key":"92530_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","volume":"34","author":"S Klein","year":"2022","unstructured":"Klein, S., Gastaldelli, A., Yki-Jarvinen, H. & Scherer, P. E. Why does obesity cause diabetes?. Cell Metab. 34, 11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.012 (2022).","journal-title":"Cell Metab."},{"key":"92530_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3945\/ajcn.116.142034","volume":"105","author":"M Guasch-Ferre","year":"2017","unstructured":"Guasch-Ferre, M. et al. Total and subtypes of dietary fat intake and risk of type 2 diabetes mellitus in the Prevencion con Dieta Mediterranea (PREDIMED) study. Am. J. Clin. Nutrit. 105, 723\u2013735. https:\/\/doi.org\/10.3945\/ajcn.116.142034 (2017).","journal-title":"Am. J. Clin. Nutrit."},{"key":"92530_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1126\/science.1230721","volume":"339","author":"JI Odegaard","year":"2013","unstructured":"Odegaard, J. I. & Chawla, A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339, 172\u2013177. https:\/\/doi.org\/10.1126\/science.1230721 (2013).","journal-title":"Science"},{"key":"92530_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040722","author":"Z Gai","year":"2019","unstructured":"Gai, Z. et al. Lipid accumulation and chronic kidney disease. Nutrients https:\/\/doi.org\/10.3390\/nu11040722 (2019).","journal-title":"Nutrients"},{"key":"92530_CR11","doi-asserted-by":"publisher","unstructured":"Mortality, G. B. D. & Causes of Death, C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117\u2013171, https:\/\/doi.org\/10.1016\/S0140-6736(14)61682-2 (2015).","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"92530_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.ki.5002017","volume":"71","author":"K Yamagata","year":"2007","unstructured":"Yamagata, K. et al. Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int. 71, 159\u2013166. https:\/\/doi.org\/10.1038\/sj.ki.5002017 (2007).","journal-title":"Kidney Int."},{"key":"92530_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"A Lim","year":"2014","unstructured":"Lim, A. Diabetic nephropathy - complications and treatment. Int. J. Nephrol. Renovasc. Dis. 7, 361\u2013381. https:\/\/doi.org\/10.2147\/IJNRD.S40172 (2014).","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"92530_CR14","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis, E. J., Hunsicker, L. G., Bain, R. P. & Rohde, R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. New Engl. J. Med. 329, 1456\u20131462. https:\/\/doi.org\/10.1056\/NEJM199311113292004 (1993).","journal-title":"New Engl. J. Med."},{"key":"92530_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl. J. Med. 345, 861\u2013869. https:\/\/doi.org\/10.1056\/NEJMoa011161 (2001).","journal-title":"New Engl. J. Med."},{"key":"92530_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. 10-year follow-up of intensive glucose control in type 2 diabetes. New Engl. J. Med. 359, 1577\u20131589. https:\/\/doi.org\/10.1056\/NEJMoa0806470 (2008).","journal-title":"New Engl. J. Med."},{"key":"92530_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","volume":"371","author":"S Zoungas","year":"2014","unstructured":"Zoungas, S. et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New Engl. J. Med. 371, 1392\u20131406. https:\/\/doi.org\/10.1056\/NEJMoa1407963 (2014).","journal-title":"New Engl. J. Med."},{"key":"92530_CR18","doi-asserted-by":"publisher","first-page":"1333553","DOI":"10.3389\/fendo.2024.1333553","volume":"15","author":"CL Yen","year":"2024","unstructured":"Yen, C. L. et al. Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia. Front. Endocrinol. Lausanne 15, 1333553. https:\/\/doi.org\/10.3389\/fendo.2024.1333553 (2024).","journal-title":"Front. Endocrinol. Lausanne"},{"key":"92530_CR19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347","author":"V Perkovic","year":"2024","unstructured":"Perkovic, V. et al. Effects of semaglutide on chronic kidney disease in patients with Type 2 diabetes. New Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2403347 (2024).","journal-title":"New Engl. J. Med."},{"key":"92530_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346. https:\/\/doi.org\/10.1038\/nm.3762 (2015).","journal-title":"Nat. Med."},{"key":"92530_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41574-023-00845-0","volume":"19","author":"A Zadoorian","year":"2023","unstructured":"Zadoorian, A., Du, X. & Yang, H. Lipid droplet biogenesis and functions in health and disease. Nat. Rev. Endocrinol. 19, 443\u2013459. https:\/\/doi.org\/10.1038\/s41574-023-00845-0 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"92530_CR22","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41581-022-00592-x","volume":"18","author":"S van der Rijt","year":"2022","unstructured":"van der Rijt, S., Leemans, J. C., Florquin, S., Houtkooper, R. H. & Tammaro, A. Immunometabolic rewiring of tubular epithelial cells in kidney disease. Nat. Rev. Nephrol. 18, 588\u2013603. https:\/\/doi.org\/10.1038\/s41581-022-00592-x (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"92530_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"M Herman-Edelstein","year":"2014","unstructured":"Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M. & Gafter, U. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J. Lipid Res. 55, 561\u2013572. https:\/\/doi.org\/10.1194\/jlr.P040501 (2014).","journal-title":"J. Lipid Res."},{"key":"92530_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105088","volume":"299","author":"H Nuskova","year":"2023","unstructured":"Nuskova, H. et al. Competition for cysteine acylation by C16:0 and C18:0 derived lipids is a global phenomenon in the proteome. J. Biol. Chem. 299, 105088. https:\/\/doi.org\/10.1016\/j.jbc.2023.105088 (2023).","journal-title":"J. Biol. Chem."},{"key":"92530_CR25","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.bbamcr.2010.07.002","volume":"1298\u20131307","author":"RF Thorne","year":"1803","unstructured":"Thorne, R. F. et al. Palmitoylation of CD36\/FAT regulates the rate of its post-transcriptional processing in the endoplasmic reticulum. Biochimica et biophysica acta 1298\u20131307, 2010. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.07.002 (1803).","journal-title":"Biochimica et biophysica acta"},{"key":"92530_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.bbrc.2015.03.094","volume":"460","author":"W Ren","year":"2015","unstructured":"Ren, W., Sun, Y. & Du, K. Glut4 palmitoylation at Cys223 plays a critical role in Glut4 membrane trafficking. Biochem. Biophys. Res. Commun. 460, 709\u2013714. https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.094 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"92530_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0005-2736(94)00272-q","volume":"1234","author":"JF Pouliot","year":"1995","unstructured":"Pouliot, J. F. & Beliveau, R. Palmitoylation of the glucose transporter in blood-brain barrier capillaries. Biochimica et biophysica acta 1234, 191\u2013196. https:\/\/doi.org\/10.1016\/0005-2736(94)00272-q (1995).","journal-title":"Biochimica et biophysica acta"},{"key":"92530_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1091\/mbc.11.2.721","volume":"11","author":"Y Zhao","year":"2000","unstructured":"Zhao, Y., McCabe, J. B., Vance, J. & Berthiaume, L. G. Palmitoylation of apolipoprotein B is required for proper intracellular sorting and transport of cholesteroyl esters and triglycerides. Mol. Biol. Cell 11, 721\u2013734. https:\/\/doi.org\/10.1091\/mbc.11.2.721 (2000).","journal-title":"Mol. Biol. Cell"},{"key":"92530_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1152\/physrev.00032.2014","volume":"95","author":"LH Chamberlain","year":"2015","unstructured":"Chamberlain, L. H. & Shipston, M. J. The physiology of protein S-acylation. Physiol. Rev. 95, 341\u2013376. https:\/\/doi.org\/10.1152\/physrev.00032.2014 (2015).","journal-title":"Physiol. Rev."},{"key":"92530_CR30","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1038\/s41467-023-42476-z","volume":"14","author":"M Gu","year":"2023","unstructured":"Gu, M. et al. Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating beta-catenin palmitoylation. Nat. Commun. 14, 6682. https:\/\/doi.org\/10.1038\/s41467-023-42476-z (2023).","journal-title":"Nat. Commun."},{"key":"92530_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","volume":"17","author":"SJ Schunk","year":"2021","unstructured":"Schunk, S. J., Floege, J., Fliser, D. & Speer, T. WNT-beta-catenin signalling - a versatile player in kidney injury and repair. Nat. Rev. Nephrol. 17, 172\u2013184. https:\/\/doi.org\/10.1038\/s41581-020-00343-w (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"92530_CR32","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/oby.20811","volume":"22","author":"Y Yang","year":"2014","unstructured":"Yang, Y., Smith, D. L. Jr., Keating, K. D., Allison, D. B. & Nagy, T. R. Variations in body weight, food intake and body composition after long-term high-fat diet feeding in C57BL\/6J mice. Obesity 22, 2147\u20132155. https:\/\/doi.org\/10.1002\/oby.20811 (2014).","journal-title":"Obesity"},{"key":"92530_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.devcel.2019.10.005","volume":"51","author":"A Ransick","year":"2019","unstructured":"Ransick, A. et al. Single-cell profiling reveals sex, lineage, and regional diversity in the mouse kidney. Dev. Cell 51, 399\u2013413. https:\/\/doi.org\/10.1016\/j.devcel.2019.10.005 (2019).","journal-title":"Dev. Cell"},{"key":"92530_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.freeradbiomed.2023.02.003","volume":"198","author":"H Shi","year":"2023","unstructured":"Shi, H. et al. Inhibition of ACSF2 protects against renal ischemia\/reperfusion injury via mediating mitophagy in proximal tubular cells. Free Radic. Biol. Med. 198, 68\u201382. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.02.003 (2023).","journal-title":"Free Radic. Biol. Med."},{"key":"92530_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1042\/EBC20200067","volume":"65","author":"S Cockcroft","year":"2021","unstructured":"Cockcroft, S. Mammalian lipids: Structure, synthesis and function. Essays Biochem 65, 813\u2013845. https:\/\/doi.org\/10.1042\/EBC20200067 (2021).","journal-title":"Essays Biochem"},{"key":"92530_CR36","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero, J. et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 48, D845\u2013D855. https:\/\/doi.org\/10.1093\/nar\/gkz1021 (2020).","journal-title":"Nucleic Acids Res."},{"key":"92530_CR37","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1681\/ASN.V9101759","volume":"9","author":"RA Orlando","year":"1998","unstructured":"Orlando, R. A. et al. Megalin is an endocytic receptor for insulin. J. Am. Soc. Nephrol. JASN 9, 1759\u20131766. https:\/\/doi.org\/10.1681\/ASN.V9101759 (1998).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"92530_CR38","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1046\/j.1523-1755.2000.00314.x","volume":"58","author":"XY Zhai","year":"2000","unstructured":"Zhai, X. Y. et al. Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney. Kidney Int. 58, 1523\u20131533. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00314.x (2000).","journal-title":"Kidney Int."},{"key":"92530_CR39","first-page":"F900","volume":"271","author":"S Cui","year":"1996","unstructured":"Cui, S., Verroust, P. J., Moestrup, S. K. & Christensen, E. I. Megalin\/gp330 mediates uptake of albumin in renal proximal tubule. Am. J. Physiol. 271, F900-907 (1996).","journal-title":"Am. J. Physiol."},{"key":"92530_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1681\/ASN.V132423","volume":"13","author":"J Gburek","year":"2002","unstructured":"Gburek, J. et al. Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J. Am. Soc. Nephrol. JASN 13, 423\u2013430. https:\/\/doi.org\/10.1681\/ASN.V132423 (2002).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"92530_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1681\/ASN.V104685","volume":"10","author":"EI Christensen","year":"1999","unstructured":"Christensen, E. I. et al. Evidence for an essential role of megalin in transepithelial transport of retinol. J. Am. Soc. Nephrol. JASN 10, 685\u2013695. https:\/\/doi.org\/10.1681\/ASN.V104685 (1999).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"92530_CR42","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.1021\/acs.analchem.9b01520","volume":"91","author":"B Zhou","year":"2019","unstructured":"Zhou, B. et al. Low-background acyl-biotinyl exchange largely eliminates the coisolation of non-S-acylated proteins and enables deep S-acylproteomic analysis. Anal. Chem. 91, 9858\u20139866. https:\/\/doi.org\/10.1021\/acs.analchem.9b01520 (2019).","journal-title":"Anal. Chem."},{"key":"92530_CR43","doi-asserted-by":"publisher","first-page":"7684","DOI":"10.1096\/fj.201802578R","volume":"33","author":"Y Gao","year":"2019","unstructured":"Gao, Y., Zhou, S., Luu, S. & Glowacki, J. Megalin mediates 25-hydroxyvitamin D(3) actions in human mesenchymal stem cells. FASEB J. 33, 7684\u20137693. https:\/\/doi.org\/10.1096\/fj.201802578R (2019).","journal-title":"FASEB J."},{"key":"92530_CR44","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1074\/jbc.M112.434159","volume":"288","author":"R Dagil","year":"2013","unstructured":"Dagil, R., O\u2019Shea, C., Nykjaer, A., Bonvin, A. M. & Kragelund, B. B. Gentamicin binds to the megalin receptor as a competitive inhibitor using the common ligand binding motif of complement type repeats: insight from the nmr structure of the 10th complement type repeat domain alone and in complex with gentamicin. J. Biol. Chem. 288, 4424\u20134435. https:\/\/doi.org\/10.1074\/jbc.M112.434159 (2013).","journal-title":"J. Biol. Chem."},{"key":"92530_CR45","doi-asserted-by":"publisher","first-page":"F337","DOI":"10.1152\/ajprenal.2001.281.2.F337","volume":"281","author":"J Nagai","year":"2001","unstructured":"Nagai, J., Tanaka, H., Nakanishi, N., Murakami, T. & Takano, M. Role of megalin in renal handling of aminoglycosides. Am. J. Physiol. Renal Physiol. 281, F337-344. https:\/\/doi.org\/10.1152\/ajprenal.2001.281.2.F337 (2001).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"92530_CR46","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina, A. et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat. Commun. 3, 735. https:\/\/doi.org\/10.1038\/ncomms1734 (2012).","journal-title":"Nat. Commun."},{"key":"92530_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107462","volume":"300","author":"O Voytyuk","year":"2024","unstructured":"Voytyuk, O., Ohata, Y., Moustakas, A., Ten Dijke, P. & Heldin, C. H. Smad7 palmitoylation by the S-acyltransferase zDHHC17 enhances its inhibitory effect on TGF-beta\/Smad signaling. J. Biol. Chem. 300, 107462. https:\/\/doi.org\/10.1016\/j.jbc.2024.107462 (2024).","journal-title":"J. Biol. Chem."},{"key":"92530_CR48","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.1073\/pnas.1710540114","volume":"114","author":"W Li","year":"2017","unstructured":"Li, W. et al. Membrane targeting of inhibitory Smads through palmitoylation controls TGF-beta\/BMP signaling. Proc. Natl. Acad. Sci. USA 114, 13206\u201313211. https:\/\/doi.org\/10.1073\/pnas.1710540114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"92530_CR49","doi-asserted-by":"publisher","first-page":"15591","DOI":"10.1073\/pnas.2002391117","volume":"117","author":"MA Lone","year":"2020","unstructured":"Lone, M. A. et al. Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases. Proc. Natl. Acad. Sci. USA 117, 15591\u201315598. https:\/\/doi.org\/10.1073\/pnas.2002391117 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"92530_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042 (2012).","journal-title":"Cell"},{"key":"92530_CR51","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1681\/ASN.2014030262","volume":"25","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A. et al. Regulated cell death in AKI. J. Am. Soc. Nephrol. JASN 25, 2689\u20132701. https:\/\/doi.org\/10.1681\/ASN.2014030262 (2014).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"92530_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06156-x","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes. Diabetologia https:\/\/doi.org\/10.1007\/s00125-024-06156-x (2024).","journal-title":"Diabetologia"},{"key":"92530_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fcell.2019.00109","volume":"7","author":"AM Ernst","year":"2019","unstructured":"Ernst, A. M., Toomre, D. & Bogan, J. S. Acylation - a new means to control traffic through the golgi. Front. Cell Dev. Biol. 7, 109. https:\/\/doi.org\/10.3389\/fcell.2019.00109 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"92530_CR54","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bbalip.2006.03.010","volume":"1761","author":"Y Ohno","year":"2006","unstructured":"Ohno, Y., Kihara, A., Sano, T. & Igarashi, Y. Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins. Biochimica et biophysica acta 1761, 474\u2013483. https:\/\/doi.org\/10.1016\/j.bbalip.2006.03.010 (2006).","journal-title":"Biochimica et biophysica acta"},{"key":"92530_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/s0092-8674(00)80655-8","volume":"96","author":"A Nykjaer","year":"1999","unstructured":"Nykjaer, A. et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507\u2013515. https:\/\/doi.org\/10.1016\/s0092-8674(00)80655-8 (1999).","journal-title":"Cell"},{"key":"92530_CR56","doi-asserted-by":"publisher","first-page":"F1284","DOI":"10.1152\/ajprenal.00030.2020","volume":"318","author":"Q Ren","year":"2020","unstructured":"Ren, Q. et al. Distinct functions of megalin and cubilin receptors in recovery of normal and nephrotic levels of filtered albumin. Am. J. Physiol. Renal Physiol. 318, F1284\u2013F1294. https:\/\/doi.org\/10.1152\/ajprenal.00030.2020 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"92530_CR57","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1152\/physrev.00008.2018","volume":"99","author":"J van der Wijst","year":"2019","unstructured":"van der Wijst, J., Belge, H., Bindels, R. J. M. & Devuyst, O. Learning physiology from inherited kidney disorders. Physiol. Rev. 99, 1575\u20131653. https:\/\/doi.org\/10.1152\/physrev.00008.2018 (2019).","journal-title":"Physiol. Rev."},{"key":"92530_CR58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1681\/ASN.2015101168","volume":"28","author":"KP Mori","year":"2017","unstructured":"Mori, K. P. et al. Increase of total nephron albumin filtration and reabsorption in diabetic nephropathy. J. Am. Soc. Nephrol. JASN 28, 278\u2013289. https:\/\/doi.org\/10.1681\/ASN.2015101168 (2017).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"92530_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00907-16","author":"Z Gai","year":"2016","unstructured":"Gai, Z. et al. Organic Cation Transporter 2 (OCT2-SLC22A2) overexpression may confer an increased risk of gentamicin-induced nephrotoxicity. Antimicrob. Agents Chemotherapy https:\/\/doi.org\/10.1128\/AAC.00907-16 (2016).","journal-title":"Antimicrob. Agents Chemotherapy"},{"key":"92530_CR60","doi-asserted-by":"publisher","first-page":"31936","DOI":"10.1074\/jbc.M104013200","volume":"276","author":"Y Percherancier","year":"2001","unstructured":"Percherancier, Y. et al. Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J. Biol. Chem. 276, 31936\u201331944. https:\/\/doi.org\/10.1074\/jbc.M104013200 (2001).","journal-title":"J. Biol. Chem."},{"key":"92530_CR61","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1073\/pnas.1000640107","volume":"107","author":"A Maeda","year":"2010","unstructured":"Maeda, A. et al. Palmitoylation stabilizes unliganded rod opsin. Proc. Natl. Acad. Sci. USA 107, 8428\u20138433. https:\/\/doi.org\/10.1073\/pnas.1000640107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"92530_CR62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1083\/jcb.200507067","volume":"172","author":"L Abrami","year":"2006","unstructured":"Abrami, L., Leppla, S. H. & van der Goot, F. G. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J. Cell Biol. 172, 309\u2013320. https:\/\/doi.org\/10.1083\/jcb.200507067 (2006).","journal-title":"J. Cell Biol."},{"key":"92530_CR63","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1073\/pnas.0710389105","volume":"105","author":"L Abrami","year":"2008","unstructured":"Abrami, L., Kunz, B., Iacovache, I. & van der Goot, F. G. Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 105, 5384\u20135389. https:\/\/doi.org\/10.1073\/pnas.0710389105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"92530_CR64","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ki.1996.111","volume":"49","author":"K Iseki","year":"1996","unstructured":"Iseki, K., Iseki, C., Ikemiya, Y. & Fukiyama, K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 49, 800\u2013805. https:\/\/doi.org\/10.1038\/ki.1996.111 (1996).","journal-title":"Kidney Int."},{"key":"92530_CR65","unstructured":"Ruggenenti, P. et al. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The \"Gruppo Italiano di Studi Epidemiologici in Nefrologia\" (GISEN). Kidney international. Supplement 63, S54\u201357 (1997)."},{"key":"92530_CR66","doi-asserted-by":"publisher","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","volume":"123","author":"JC Peterson","year":"1995","unstructured":"Peterson, J. C. et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann. Internal Med. 123, 754\u2013762. https:\/\/doi.org\/10.7326\/0003-4819-123-10-199511150-00003 (1995).","journal-title":"Ann. Internal Med."},{"key":"92530_CR67","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1046\/j.1523-1755.2003.00033.x","volume":"63","author":"P Ruggenenti","year":"2003","unstructured":"Ruggenenti, P., Perna, A., Remuzzi, G. & Investigators, G. G. Retarding progression of chronic renal disease: The neglected issue of residual proteinuria. Kidney Int. 63, 2254\u20132261. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00033.x (2003).","journal-title":"Kidney Int."},{"key":"92530_CR68","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/bmj.304.6823.339","volume":"304","author":"S Bjorck","year":"1992","unstructured":"Bjorck, S., Mulec, H., Johnsen, S. A., Norden, G. & Aurell, M. Renal protective effect of enalapril in diabetic nephropathy. Bmj 304, 339\u2013343. https:\/\/doi.org\/10.1136\/bmj.304.6823.339 (1992).","journal-title":"Bmj"},{"key":"92530_CR69","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"D de Zeeuw","year":"2004","unstructured":"de Zeeuw, D. et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110, 921\u2013927. https:\/\/doi.org\/10.1161\/01.CIR.0000139860.33974.28 (2004).","journal-title":"Circulation"},{"key":"92530_CR70","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","volume":"45","author":"H Ibsen","year":"2005","unstructured":"Ibsen, H. et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 45, 198\u2013202. https:\/\/doi.org\/10.1161\/01.HYP.0000154082.72286.2a (2005).","journal-title":"Hypertension"},{"key":"92530_CR71","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","volume":"51","author":"M Wuttke","year":"2019","unstructured":"Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957\u2013972. https:\/\/doi.org\/10.1038\/s41588-019-0407-x (2019).","journal-title":"Nat. Genet."},{"key":"92530_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106363","volume":"144","author":"H Kuwata","year":"2019","unstructured":"Kuwata, H. & Hara, S. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism. Prostaglandins Other Lipid Mediators 144, 106363. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106363 (2019).","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"92530_CR73","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1124\/dmd.118.081091","volume":"46","author":"M Visentin","year":"2018","unstructured":"Visentin, M. et al. Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors. Drug Metab. Disposit. 46, 1129\u20131136. https:\/\/doi.org\/10.1124\/dmd.118.081091 (2018).","journal-title":"Drug Metab. Disposit."},{"key":"92530_CR74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161908","author":"MA Lone","year":"2022","unstructured":"Lone, M. A. et al. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins. J. Clin. Investig. https:\/\/doi.org\/10.1172\/JCI161908 (2022).","journal-title":"J. Clin. Investig."},{"key":"92530_CR75","doi-asserted-by":"publisher","DOI":"10.1515\/jib-2022-0031","author":"C Panse","year":"2022","unstructured":"Panse, C., Trachsel, C. & Turker, C. Bridging data management platforms and visualization tools to enable ad-hoc and smart analytics in life sciences. J. Integr. Bioinform. https:\/\/doi.org\/10.1515\/jib-2022-0031 (2022).","journal-title":"J. Integr. Bioinform."},{"key":"92530_CR76","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344. https:\/\/doi.org\/10.1038\/s41592-019-0638-x (2020).","journal-title":"Nat. Methods"},{"key":"92530_CR77","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1021\/acs.jproteome.2c00441","volume":"22","author":"WE Wolski","year":"2023","unstructured":"Wolski, W. E. et al. prolfqua: A comprehensive R-package for proteomics differential expression analysis. J. Proteome Res. 22, 1092\u20131104. https:\/\/doi.org\/10.1021\/acs.jproteome.2c00441 (2023).","journal-title":"J. Proteome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92530-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:15:41Z","timestamp":1741158941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92530-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92530"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92530-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Experiments involving animals are described in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"7689"}}